Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer
Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer
Recruiting · NCT05640791 · Registry updated 2026-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer | Resectable Biliary Tract Cancer | Recruiting | Phase 2 | 2026-07-16 | NCT05640791 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tianjin Medical University Cancer Institute and Hospital | 287 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tianjin Cancer Hospital Airport Hospital | Tianjin | China | 18 |